SNGX READ THE FULL SNGX RESEARCH REPORT Business Update Presentation Highlights HyBryte Potential in CTCL In January 2025, Dr ...

The United States Cutaneous Lymphoma Consortium is a multidisciplinary society of physicians which use collaborative research and education to improve the quality of life and prognosis of patients ...

Two Presentations Highlight Data Demonstrating Hypericin Photodynamic Therapy Potential with a Preliminary Comparison to Current Therapy ...

Symptom control is often the goal for patients who have mycosis fungoides, the most common type of cutaneous T-cell lymphoma. Mycosis fungoides tends to advance slowly, so symptom control can help you ...

It can lead to rash-like redness, scaly patches or plaques, and tumors. The most common type of cutaneous T-cell lymphoma is called mycosis fungoides. A less common form, Sezary syndrome, can lead to ...

Innate Pharma has secured US Food and Drug Administration (FDA) breakthrough therapy designation for lacutamab to treat adults with relapsed or refractory Sézary syndrome.

Cancers that can cause this include cancers in the bile duct, pancreatic cancer, and cancer in the liver. Mast cells and histamine release: Some cancers, such as mycosis fungoides (a type of cutaneous ...